Navigation Links
Research highlights role of protein pair in obesity regulation
Date:2/12/2010

CINCINNATINew research by University of Cincinnati (UC) scientists implicates a new protein in obesity development and highlights a protein pair's "team effort" in regulating obesity and insulin resistance.

Jorge Moscat, PhD, chair of UC's cancer and cell biology department, says that proteins p62 and ERK are involved in adipogeneis, (the development of adipocytes, or fat cells). His new study shows precisely how this duo works together.

The study is published online in advance of print Friday, Feb. 12, 2010, in the journal EMBO Reports, and will appear in print in the March 1, 2010, edition.

Earlier research led by Moscat showed that removing or "knocking out" p62 in mice led to the development of obesity and insulin resistance in adulthood. These mice used less energy and created more fat cells than the control group, even with the same diet and activity levels.

Targeting p62 mutations or deficiencies seemed to be a logical next step for potential obesity treatments; however, Moscat says, p62 is not an easy target due to its lack of enzymatic action. In other words, it does not catalyze reactions in a way that would be key for the success of targeted drug therapy. In addition, missing or mutated p62 has also been linked to cancer development.

Moscat and his team instead decided to focus their attention on the action of another less-understood protein, ERK, which interacts with p62.

"Thoughts about ERK's role in obesity have been controversial," says Moscat. "One theory suggested that it was to restrain production of fat cells. Our study shows a much more devious role for ERK."

In the new study, Moscat and his team bred mice without p62 and ERK. These "double knockouts" did not develop obesity like the p62 knockouts did, indicating that ERK was the obesity-inducing culprit.

The team's findings show that p62 works to suppress the action of ERK, so without p62, ERK activity goes uncontrolled.

Moscat says that ERK serves as a better target for obesity therapies because it could be inhibited without affecting p62.


'/>"/>

Contact: Dama Kimmon
dama.kimmon@uc.edu
513-558-4519
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
2. GUMCs Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine
3. MSU researcher linking breast cancer patients with alternative therapies
4. Researchers create drug to keep tumor growth switched off
5. Tiny fruit fly could offer big clues in fight against obesity, researcher says
6. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
7. New Research Examines Impact of Health Care Reform on Regional Health Plans
8. Prevention Is Key Research Goal for Premature Babies, Scientists Say
9. Stuttering Foundation Hails New Research
10. Gladstones Robert Mahley to receive Research!America advocacy award
11. International Diabetes Federation awards $2 million to 9 global diabetes research projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... ... From May 4 to 6, EarQ and Signia co-sponsored a ... more about Signia’s technology and the successful business and marketing techniques that make EarQ ... practices succeed in this highly competitive industry,” said Ed Keller, president of EarQ. “This ...
(Date:5/6/2016)... Diego, CA (PRWEB) , ... May 06, 2016 , ... ... Companies, has been family-owned and operated for over 35 years. Maintaining core values of ... has driven their success and made them a leading name in San Diego plumbing, ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... System and David Konur, CEO of Cardiovascular Institute of the South announced today ... be performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/5/2016)... ... May 05, 2016 , ... Pivot Point Consulting ... gold standard KLAS Performance Report, Epic Consulting 2016 - Which Firms ... specialize in consulting services for electronic health record (EHR) solutions from Epic ...
(Date:5/5/2016)... Tampa, FL (PRWEB) , ... May 05, 2016 ... ... hospital in Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative ... (LAAC) Implant. Since first offering the procedure in April of 2015, Florida Hospital ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
(Date:5/3/2016)... Global Insulin Needles Industry ... key companies and supported with 272 tables and ... on the current state of the Insulin Needles ... including definitions, classifications, applications and industry chain structure. ... the international market including development history, competitive landscape ...
(Date:5/3/2016)... May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, ... - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
Breaking Medicine Technology: